Startups

MicroPort Scientific
Shanghai, China · Hong Kong
MicroPort Scientific Corporation is a Shanghai-based medical-device group listed on the Hong Kong Stock Exchange under stock code 00853 and incorporated in the Cayman Islands. Its operating business began in Shanghai in 1998. The group develops and markets cardiovascular, orthopedic, cardiac-rhythm, endovascular, neurovascular and structural-heart devices, medical imaging and surgical robotics. Its published leadership includes a function responsible for AI manufacturing and global supply chains. Strategic investments include Promaxo’s portable MRI technology and NDR Medical’s AI-assisted needle-targeting robotics. The listed parent is distinct from separately listed and operated companies such as MicroPort NeuroScientific, MicroPort MedBot, MicroPort CardioFlow and MicroPort Endovascular. Jonathan W Chen is the current rotating chief executive; founder Zhaohua Chang chairs the board and serves as chief scientific officer. The parent’s financing history includes its 2010 IPO, equity placements, convertible bonds and drawn corporate loans. Fundraising by subsidiaries and cumulative group financing totals are separate from parent-company proceeds.
Founded 1998





















